ML VENTURE PARTNERS II LP
10-Q, 1999-05-14
Previous: SUNGARD DATA SYSTEMS INC, 10-Q, 1999-05-14
Next: MCLAREN AUTOMOTIVE GROUP INC, 10QSB, 1999-05-14



                                             SECURITIES AND EXCHANGE COMMISSION
                                                    Washington, D.C. 20549

                                    FORM 10-Q

[X]      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934

For the Quarterly Period Ended March 31, 1999

Or

[  ]     Transition Report Pursuant to Section 13 or 15(d) of the Securities 
         Exchange Act of 1934

For the transition period from                  to
                             Commission file number 0-14217

                             ML VENTURE PARTNERS II, L.P.
- -------------------------------------------------------------------------------
                    (Exact name of registrant as specified in its charter)


Delaware                                                            13-3324232
- -------------------------------------------------------------------------------
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
incorporation or organization)

World Financial Center, North Tower
New York, New York                                                  10281-1326
- -------------------------------------------------------------------------------
(Address of principal executive offices)                             (Zip Code)

Registrant's telephone number, including area code: (212) 449-1000

Not applicable
- -------------------------------------------------------------------------------
Former name, former address and former fiscal year, if changed since last report


     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes X No


<PAGE>


                               ML VENTURE PARTNERS II, L.P.

                                      INDEX



PART I.       FINANCIAL INFORMATION

Item 1.       Financial Statements.

Balance Sheets as of March 31, 1999 (Unaudited) and December 31, 1998

Schedule of Portfolio Investments as of March 31, 1999 (Unaudited)

Statements of Operations for the Three Months Ended March 31, 1999 and 1998 
(Unaudited)

Statements of Cash Flows for the Three Months Ended March 31, 1999 and 1998 
(Unaudited)

Statement of Changes in Partners' Capital for the Three Months Ended March 31, 
1999 (Unaudited)

Notes to Financial Statements (Unaudited)

Item 2.       Management's Discussion and Analysis of Financial Condition and 
              Results of Operations.

Item 3.       Quantitative and Qualitative Disclosures about Market Risk.

PART II.      OTHER INFORMATION

Item 1.       Legal Proceedings.

Item 2.       Changes in Securities.

Item 3.       Defaults upon Senior Securities.

Item 4.       Submission of Matters to a Vote of Security Holders.

Item 5.       Other Information.

Item 6.       Exhibits and Reports on Form 8-K.



<PAGE>


                                 PART I - FINANCIAL INFORMATION


Item 1.       Financial Statements.

ML VENTURE PARTNERS II, L.P.
BALANCE SHEETS
<TABLE>

                                                                                          March 31, 1999       December 31,
                                                                                            (Unaudited)              1998        
ASSETS

<S>                                        <C>             
Portfolio investments, at fair value (cost $9,834,307 as of
   March 31, 1999 and $10,197,685 as of December 31, 1998)                                $     13,814,513     $     14,970,273
Short-term investments, at amortized cost                                                          496,249            4,488,454
Cash and cash equivalents                                                                          257,435              423,675
Receivable from liquidated securities                                                                    -              475,435
Accrued interest receivable                                                                              -                1,291
                                                                                          ----------------     ----------------

TOTAL ASSETS                                                                              $     14,568,197     $     20,359,128
                                                                                          ================     ================


LIABILITIES AND PARTNERS' CAPITAL

Liabilities:
Cash distribution payable                                                                 $              -     $      4,514,772
Accounts payable and accrued expenses                                                              115,545               85,874
Due to Management Company                                                                           50,000              100,410
Due to Independent General Partners                                                                 24,000               19,870
                                                                                          ----------------     ----------------
   Total liabilities                                                                               189,545            4,720,926
                                                                                          ----------------     ----------------

Partners' Capital:
Managing General Partner                                                                           576,261              652,777
Individual General Partners                                                                            327                  341
Limited Partners (120,000 Units)                                                                 9,821,858           10,212,496
Unallocated net unrealized appreciation of portfolio investments                                 3,980,206            4,772,588
                                                                                          ----------------     ----------------
   Total partners' capital                                                                      14,378,652           15,638,202
                                                                                          ----------------     ----------------

TOTAL LIABILITIES AND PARTNERS' CAPITAL                                                   $     14,568,197     $     20,359,128
                                                                                          ================     ================

</TABLE>

See notes to financial statements


<PAGE>


ML VENTURE PARTNERS II, L.P.
SCHEDULE OF PORTFOLIO INVESTMENTS (Unaudited)
As of March 31, 1999
<TABLE>
<S>     <C>    <C>    <C>    <C>    <C>    <C>

                                                                       Initial Investment
Company / Position                                                            Date                 Cost              Fair Value
Borg-Warner Security Corporation* (A)
<C>                                                                             <C>           <C>               <C>            
500,000 shares of Common Stock                                            Sept. 1988          $    2,500,000    $     6,281,250
- -------------------------------------------------------------------------------------------------------------------------------
Brightware, Inc. (B)
   200,057 shares of Common Stock                                         May 1995                    44,703            300,086
- -------------------------------------------------------------------------------------------------------------------------------
Clarus Medical Systems, Inc.*
179,028 shares of Preferred Stock                                         Jan. 1991                1,000,548            895,152
Warrants to purchase 14,043 shares of Common Stock
   at $.05 per share, expiring between 3/7/00 and 7/3/00                                                   0                  0
Warrants to purchase 2,826 shares of Preferred Stock
   at $5.00 per share, expiring on 3/7/00                                                                  0                  0
- -------------------------------------------------------------------------------------------------------------------------------
CoCensys, Inc. (A)
152,507 shares of Common Stock                                            Feb. 1989                  192,504             24,782
- -------------------------------------------------------------------------------------------------------------------------------
Corporate Express, Inc. (A)
60,000 shares of Common Stock                                             May 1992                    12,000            249,000
- -------------------------------------------------------------------------------------------------------------------------------
Diatide, Inc.* (A)
809,704 shares of Common Stock                                            Dec. 1991                2,986,023          2,171,019
- -------------------------------------------------------------------------------------------------------------------------------
I.D.E. Corporation
113,322 shares of Common Stock                                            Mar. 1988                  227,000                  0
- -------------------------------------------------------------------------------------------------------------------------------
Photon Dynamics, Inc.* (A)
425,236 shares of Common Stock                                            Sept. 1988               2,452,226          3,027,062
Warrants to purchase 6,062 shares of Common Stock
   at $5.40 per share, expiring on 6/30/00                                                                 0                  0
- -------------------------------------------------------------------------------------------------------------------------------
Raytel Medical Corporation(A)
62,500 shares of Common Stock                                             Feb. 1990                  241,639            206,250
Options to purchase 27,969 shares of Common Stock
   at $1.42 per share, expiring on 10/31/01                                                                0             52,582
- -------------------------------------------------------------------------------------------------------------------------------
ReGen Biologics, Inc.
72,800 shares of Common Stock                                             Apr. 1991                      364            263,900
62,400 shares of Preferred Stock                                                                     114,400            226,200
- -------------------------------------------------------------------------------------------------------------------------------
Stereotaxis, Inc.
21,632 shares of Common Stock                                             Apr. 1990                      216             16,224
134,674 shares of Preferred Stock                                                                     62,684            101,006
- -------------------------------------------------------------------------------------------------------------------------------
Total Portfolio Investments                                                                   $    9,834,307    $    13,814,513
                                                                                              ---------------------------------
</TABLE>



<PAGE>


ML VENTURE PARTNERS II, L.P.
SCHEDULE OF PORTFOLIO INVESTMENTS (Unaudited), continued
March 31, 1999
<TABLE>


Supplemental Information:  Liquidated Portfolio Investments(C) (D)

                                                                                                 Net
                                                                            Cost            Realized Gain            Return    
<S>                                                                   <C>                   <C>                <C>             
Totals from Liquidated Portfolio Investments                          $   106,698,689       $  110,915,427     $    217,614,116
                                                                      =========================================================

                                                                                            Combined Net               Combined
                                                                                           Unrealized and            Fair Value
                                                                            Cost            Realized Gain            and Return

Totals from Active & Liquidated Portfolio Investments                 $   116,532,996       $  114,895,633     $    231,428,629
                                                                      =========================================================

</TABLE>

(A)  Public company

(B)  In March 1999, in a non-cash  transaction,  the  Partnership  exchanged its
     warrant to purchase  38,737 common shares of  Brightware,  Inc. at $.40 per
     share for 28,407 shares of Brightware common stock.

(C) In March 1999, the Partnership wrote-off its remaining investment in Neocrin
Company, realizing a loss of $363,378.

(D)  Amounts  provided  for  "Supplemental  Information:   Liquidated  Portfolio
Investments" are cumulative from inception through March 31, 1999.

* May be deemed  an  affiliated  person of the  Partnership  as  defined  in the
Investment Company Act of 1940.


See notes to financial statements.


<PAGE>


ML VENTURE PARTNERS II, L.P.
STATEMENTS OF OPERATIONS (Unaudited)
For the Three Months Ended March 31,
<TABLE>



                                                                                               1999                  1998     
                                                                                         ---------------        --------------

INVESTMENT INCOME AND EXPENSES

Income:
<S>                                                                                     <C>                     <C>          
   Interest from short-term investments                                                 $         22,972        $      70,588
   Interest and other income from portfolio investments                                              530                    -
                                                                                        ----------------        -------------
   Total investment income                                                                        23,502               70,588
                                                                                        ----------------        -------------

Expenses:
   Management fee                                                                                 50,000               50,000
   Professional fees                                                                              26,340               30,068
   Mailing and printing                                                                           25,467               27,152
   Independent General Partners' fees                                                             24,000               24,000
   Custodial fees                                                                                  1,011                   99
   Miscellaneous                                                                                     474                  189
                                                                                        ----------------        -------------
   Total investment expenses                                                                     127,292              131,508
                                                                                        ----------------        -------------

NET INVESTMENT LOSS                                                                             (103,790)             (60,920)

Net realized loss from portfolio investments                                                    (363,378)                   -
                                                                                        ----------------        -------------

NET REALIZED LOSS FROM OPERATIONS                                                               (467,168)             (60,920)

Change in net unrealized appreciation of portfolio investments                                  (792,382)           1,001,583
                                                                                        ----------------        -------------

NET (DECREASE) INCREASE IN NET ASSETS
   RESULTING FROM OPERATIONS                                                            $     (1,259,550)       $     940,663
                                                                                        ================        =============

</TABLE>

See notes to financial statements.



<PAGE>


ML VENTURE PARTNERS II, L.P.
STATEMENTS OF CASH FLOWS (Unaudited)
For the Three Months Ended March 31,
<TABLE>


                                                                                              1999                   1998      
                                                                                        ----------------        ---------------

CASH FLOWS USED FOR OPERATING ACTIVITIES

<S>                                                                                     <C>                     <C>             
Net investment loss                                                                     $       (103,790)       $       (60,920)

Adjustments  to  reconcile  net  investment  loss to  cash  used  for  operating
   activities:

Decrease (increase) in accrued interest and accounts receivable                                    1,291                 (4,399)
Decrease in accrued interest from short-term investments                                          31,428                  3,343
(Decrease) increase in payables                                                                  (16,609)                 6,518
                                                                                        ----------------        ---------------
Cash used for operating activities                                                               (87,680)               (55,458)
                                                                                        ----------------        ---------------

CASH FLOWS PROVIDED FROM (USED FOR)
   INVESTING ACTIVITIES

Net return (purchase) of short-term investments                                                3,960,777             (1,485,862)
Net proceeds from the sale of portfolio investments                                              475,435                      -
                                                                                        ----------------        ---------------
Cash provided from (used for) investing activities                                             4,436,212             (1,485,862)
                                                                                        ----------------        ---------------

CASH FLOWS USED FOR FINANCING ACTIVITES

Cash distribution paid to partners                                                            (4,514,772)                     -
                                                                                        ----------------        ---------------

Decrease in cash and cash equivalents                                                           (166,240)            (1,541,320)
Cash and cash equivalents at beginning of period                                                 423,675              1,918,335
                                                                                        ----------------        ---------------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                                              $        257,435        $       377,015
                                                                                        ================        ===============


</TABLE>

See notes to financial statements.


<PAGE>


ML VENTURE PARTNERS II, L.P.
STATEMENT OF CHANGES IN PARTNERS' CAPITAL (Unaudited)
For the Three Months Ended March 31, 1999
<TABLE>



                                                                                              Unallocated
                                         Managing        Individual                         Net Unrealized
                                          General          General           Limited         Appreciation
                                          Partner         Partners          Partners         of Investments          Total     

<S>                                    <C>                <C>           <C>                 <C>                <C>             
Balance at beginning of period         $     652,777      $    341      $   10,212,496      $    4,772,588     $     15,638,202

Net investment loss                             (933)           (4)           (102,853)                  -             (103,790)

Net realized loss from portfolio
   investments                               (75,583)          (10)           (287,785)                  -             (363,378)

Change in unrealized
   appreciation of investments                     -             -                   -            (792,382)            (792,382)
                                       -------------      --------      --------------      --------------     ----------------

Balance at end of period               $     576,261      $    327      $    9,821,858 (A)  $    3,980,206     $     14,378,652
                                       =============      ========      ===============     ==============     ================

</TABLE>


(A)  The net asset value per unit of limited partnership interest,  including an
     assumed allocation of net unrealized appreciation of investments,  was $108
     as of March 31, 1999.  Additionally,  cumulative cash distributions paid to
     limited partners from inception to March 31, 1999 totaled $1,560 per Unit.


See notes to financial statements.


<PAGE>


ML VENTURE PARTNERS II, L.P.
NOTES TO FINANCIAL STATEMENTS (Unaudited)


1.     Organization and Purpose

ML  Venture  Partners  II,  L.P.  (the  "Partnership")  is  a  Delaware  limited
partnership  formed on February 4, 1986.  MLVPII Co., L.P., the managing general
partner  of  the  Partnership  (the  "Managing  General   Partner"),   and  four
individuals (the "Individual  General Partners") are the general partners of the
Partnership.  The general  partner of MLVPII Co.,  L.P. is Merrill Lynch Venture
Capital Inc. (the "Management Company"), an indirect subsidiary of Merrill Lynch
& Co., Inc. DLJ Capital Management Corporation (the "Sub-Manager"),  an indirect
subsidiary of Donaldson,  Lufkin & Jenrette,  Inc.,  is the  sub-manager  of the
Partnership,  pursuant to a sub-management agreement among the Partnership,  the
Management Company, the Managing General Partner and the Sub-Manager.

The Partnership's  objective is to achieve  long-term capital  appreciation from
its portfolio of venture capital investments in new and developing companies and
other special  investment  situations.  The  Partnership  does not engage in any
other business or activity.  The Managing  General Partner is working toward the
ultimate  termination of the  Partnership,  with an emphasis on liquidating  the
remaining  assets as soon as practical  with the goal of  maximizing  returns to
Partners. In July 1997, the Individual General Partners voted to extend the term
of the Partnership  for an additional  two-year  period.  The Partnership is now
scheduled  to  terminate no later than  December  31,  1999.  In  addition,  the
Individual General Partners have the right to extend the term of the Partnership
for an additional  two-year  period if they  determine that such extension is in
the best interest of the Partnership.

2.     Significant Accounting Policies

Valuation of Investments - Short-term  investments are carried at amortized cost
which approximates  market.  Portfolio  investments are carried at fair value as
determined  quarterly by the Sub-Manager under the supervision of the Individual
General  Partners  and  the  Managing   General  Partner.   The  fair  value  of
publicly-held  portfolio  securities  is adjusted to the closing  public  market
price for the last trading day of the accounting  period  discounted by a factor
of 0% to 50% for sales restrictions.  Factors considered in the determination of
an  appropriate  discount  include,  underwriter  lock-up  or Rule  144  trading
restrictions,  insider status where the Partnership  either has a representative
serving  on  the  company's  Board  of  Directors  or  is  greater  than  a  10%
shareholder,  and other liquidity  factors such as the size of the Partnership's
position  in a given  company  compared  to the  trading  history  of the public
security.   Privately-held  portfolio  securities  are  carried  at  cost  until
significant  developments  affecting the portfolio  company  provide a basis for
change in  valuation.  The fair value of private  securities  is  adjusted 1) to
reflect  meaningful  third-party  transactions  in the  private  market or 2) to
reflect  significant  progress or slippage in the  development  of the company's
business  such that cost is no longer  reflective  of fair  value.  As a venture
capital investment fund, the Partnership's  portfolio investments involve a high
degree of business and financial risk that can result in substantial losses. The
Sub-Manager   considers  such  risks  in  determining  the  fair  value  of  the
Partnership's portfolio investments.


<PAGE>
ML VENTURE PARTNERS II, L.P.
NOTES TO FINANCIAL STATEMENTS (Unaudited), continued

Use of Estimates - The  preparation of financial  statements in conformity  with
generally accepted  accounting  principles requires management to make estimates
and assumptions  that affect the reported  amounts of assets and liabilities and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting period. Actual results could differ from those estimates.

Investment  Transactions - Investment  transactions  are recorded on the accrual
method.  Portfolio  investments  are  recorded on the trade  date,  the date the
Partnership  obtains an  enforceable  right to demand the  securities or payment
therefor.  Realized  gains and  losses on  investments  sold are  computed  on a
specific identification basis.

Income Taxes - No provision  for income taxes has been made since all income and
losses are  allocable  to the partners for  inclusion  in their  respective  tax
returns.  The Partnership's net assets for financial  reporting  purposes differ
from its net assets for tax purposes. Net unrealized appreciation of investments
of  approximately  $4.0  million as of March 31,  1999,  which was  recorded for
financial statement purposes, was not recognized for tax purposes. Additionally,
from  inception to March 31, 1999,  timing  differences  of  approximately  $6.4
million  have  been  deducted  on the  Partnership's  financial  statements  and
syndication  costs  relating to the selling of Units totaling $11.3 million were
charged to partners' capital on the financial statements. These amounts have not
been deducted or charged against partners' capital for tax purposes.

Statements of Cash Flows - The Partnership  considers its interest-bearing  cash
account to be cash equivalents.

Reclassifications - Certain reclassifications have been made to the prior period
financial statements to conform with the current period presentation.

3.     Allocation of Partnership Profits and Losses

The  Partnership  Agreement  provides that the Managing  General Partner will be
allocated,  on a cumulative basis over the life of the  Partnership,  20% of the
Partnership's aggregate investment income and net realized gains and losses from
venture capital  investments,  provided that such amount is positive.  All other
gains and  losses  of the  Partnership  are  allocated  among  all the  Partners
(including  the Managing  General  Partner) in  proportion  to their  respective
capital contributions to the Partnership.  From its inception to March 31, 1999,
the  Partnership had a $115.2 million net realized gain from its venture capital
investments, which includes interest and other income from portfolio investments
totaling $4.3 million.

4.     Related Party Transactions

The  Management  Company  performs,  or  arranges  for  others to  perform,  the
management  and  administrative  services  necessary  for the  operation  of the
Partnership  and  receives a  management  fee at the annual  rate of 2.5% of the
gross capital contributions to the Partnership,  reduced by selling commissions,
organizational   and  offering   expenses  paid  by  the  Partnership,   capital
distributed  and realized  capital losses with a minimum annual fee of $200,000.
Such fee is determined and payable quarterly.


<PAGE>


ML VENTURE PARTNERS II, L.P.
NOTES TO FINANCIAL STATEMENTS (Unaudited), continued

5.     Independent General Partners' Fees

As  compensation  for services  rendered to the  Partnership,  each of the three
Independent   General   Partners   receives   $20,000   annually  in   quarterly
installments,  $1,500 for each meeting of the General  Partners  attended or for
each other  meeting,  conference or engagement  in connection  with  Partnership
activities at which attendance by an Independent General Partner is required and
$1,500 for each audit  committee  meeting  attended ($500 if an audit  committee
meeting  is  held  on the  same  day as a  meeting  of the  Independent  General
Partners).

6.       Interim Financial Statements

In the  opinion  of  MLVPII  Co.,  L.P.  the  managing  general  partner  of the
Partnership,  the unaudited  financial  statements as of March 31, 1999, and for
the three month period then ended,  reflect all  adjustments  necessary  for the
fair presentation of the results of the interim period.

7.       Subsequent Event

Subsequent  to the end of the quarter  through April 26, 1999,  the  Partnership
sold 221,000 common shares of Photon Dynamics, Inc. for $2,225,850,  realizing a
gain of $951,400.

8.     Classification of Portfolio Investments

As of March 31, 1999, the Partnership's  investments in portfolio companies were
categorized as follows:
<TABLE>

                                                                                               % of
Type of Investments                                  Cost               Fair Value          Net Assets*
- -------------------                             --------------        ---------------       -----------
<S>                                             <C>                   <C>                     <C>   
Common Stock and Warrants                       $    8,656,675        $    12,592,155         87.58%
Preferred Stock                                      1,177,632              1,222,358          8.50%
                                                --------------        ---------------        -------
Total                                           $    9,834,307        $    13,814,513         96.08%
                                                ==============        ===============         ======

Country/Geographic Region
Midwestern U.S.                                 $    3,575,448        $     7,542,632         52.46%
Western U.S.                                         3,045,836              4,100,862         28.52%
Eastern U.S.                                         3,213,023              2,171,019         15.10%
                                                --------------        ---------------         ------
Total                                           $    9,834,307        $    13,814,513         96.08%
                                                ==============        ===============         ======

Industry
Business Services                               $    2,512,000        $     6,530,250         45.41%
Biotechnology                                        3,356,191              2,803,131         19.50%
Semiconductors/Electronics                           2,452,226              3,027,062         21.05%
Medical Devices and Services                         1,242,187              1,153,984          8.03%
Computer Hardware/Software                             271,703                300,086          2.09%
                                                --------------        ---------------        -------
Total                                           $    9,834,307        $    13,814,513         96.08%
                                                ==============        ===============         ======
</TABLE>

* Percentage of net assets is based on fair value.
<PAGE>

Item 2.       Management's Discussion and Analysis of Financial Condition and 
              Results of Operations.

Liquidity and Capital Resources

As of March 31, 1999, the  Partnership  held $496,249 in short-term  investments
with maturities of less than one year and $257,435 in an  interest-bearing  cash
account.  Interest  earned from such  investments  totaled $22,972 for the three
months ended March 31,  1999.  Interest  earned in future  periods is subject to
fluctuations in short-term  interest rates and changes in amounts  available for
investment in such securities.  Funds needed to cover the  Partnership's  future
operating  expenses  and  follow-on   investments  will  be  obtained  from  the
Partnership's existing cash reserves,  from interest and other investment income
received and from proceeds received from the sale of portfolio investments.

The  Managing   General  Partner  is  working  toward  the  termination  of  the
Partnership  as soon as  practical,  with  the  goal of  maximizing  returns  to
partners. In July 1997, the Individual General Partners voted to extend the term
of the Partnership  for an additional  two-year  period.  The Partnership is now
scheduled  to  terminate no later than  December  31,  1999.  In  addition,  the
Individual General Partners have the right to extend the term of the Partnership
for an additional  two-year  period if they  determine that such extension is in
the best interest of the Partnership.

The  Partnership  will  not make  additional  investments  in any new  portfolio
companies.   Generally,  net  proceeds  received  from  the  sale  of  portfolio
investments  are  distributed  to  Partners  as soon as  practicable,  after  an
adequate  reserve  for  operating  expenses  and  follow-on  investments  in the
remaining portfolio companies.

Subsequent to the end of the quarter through April 26, 1999, the Partnership  
sold 221,000 common shares of Photon  Dynamics,  Inc. for $2,225,850.  See 
Note 7 of Notes to Financial Statements.

Results of Operations

For the three months ended March 31, 1999 and 1998,  the  Partnership  had a net
realized  loss from  operations  of  $467,168  and  $60,920,  respectively.  Net
realized  gain or loss from  operations  is comprised of 1) net realized gain or
loss from portfolio  investments and 2) net investment income or loss (interest,
dividend and other portfolio income less operating expenses).

Realized  Gains and Losses from  Portfolio  Investments  - For the three  months
ended March 31, 1999, the Partnership had a $363,378 net realized loss resulting
from the  write-off  of its  remaining  investment  in  Neocrin  Company  due to
continued operating and financial difficulties at the company.

The Partnership  had no realized gains or losses from portfolio  investments for
the three months ended March 31, 1998.

Investment  Income and  Expenses - For the three months ended March 31, 1999 and
1998,  the  Partnership  had a net  investment  loss of  $103,790  and  $60,920,
respectively.  The increase in net investment  loss for the 1999 period compared
to the same period in 1998, was primarily  attributable to a $47,086 decrease in
investment  income for the 1999 period  compared to the same period in 1998. The
decline in investment income primarily resulted from a decrease in interest from
short-term  investments,  primarily  due to a decrease  in funds  available  for
investment in such  securities  during the first quarter of 1999 compared to the
same period in 1998.  Operating  expenses of $127,292 for the three months ended
March 31, 1999 were slightly lower than  operating  expenses of $131,508 for the
three months ended March 31, 1998.

The  Management  Company is responsible  for the  management and  administrative
services necessary for the operation of the Partnership.  The Management Company
receives  a  management  fee at an  annual  rate of 2.5%  of the  gross  capital
contributions to the Partnership, reduced by selling commissions, organizational
and offering  expenses paid by the  Partnership,  return of capital and realized
capital  losses,  with a minimum annual fee of $200,000.  Such fee is determined
and payable  quarterly.  The management fee for the three months ended March 31,
1999 and 1998, was $50,000.  The management fee and other operating expenses are
paid with funds provided from operations and from existing cash reserves.  Funds
provided from  operations  for the period were  obtained from interest  received
from short-term investments.

Unrealized Gains and Losses and Changes in Unrealized  Appreciation of Portfolio
Investments - For the three months ended March 31, 1999, the Partnership reduced
the  fair  value  of its  remaining  portfolio  investments  on a net  basis  by
$1,155,760.  Additionally,  during the quarter,  $363,378 of unrealized loss was
transferred to realized loss relating to the write-off of Neocrin Company during
the quarter,  as discussed  above.  As a result,  the Partnership had a $792,382
unfavorable  change in net unrealized  appreciation of investments for the three
months ended March 31, 1999.

For the three months ended March 31, 1998,  the  Partnership  increased the fair
value of its  remaining  portfolio  investments  on a net  basis by  $1,001,583,
increasing net unrealized appreciation of investments for the three month period
ended March 31, 1998.

Net Assets - Changes to net assets  resulting  from  operations  are comprised 
of 1) net realized gain or loss from  operations  and 2)changes to net 
unrealized appreciation of portfolio investments.

As of March 31,  1999,  the  Partnership's  net assets  were  $14,378,652,  down
$1,259,550 from $15,638,202 as of December 31, 1998. This decrease was comprised
of the $467,168 net realized loss from  operations and the $792,382  decrease in
net unrealized  appreciation of investments for the three months ended March 31,
1999.

As of March 31, 1998, the Partnership's net assets were $22,647,856, up $940,663
from  $21,707,193  as of December 31, 1997.  This  increase was comprised of the
$1,001,583 increase in net unrealized  appreciation of investments offset by the
$60,920 net realized loss from  operations  for the three months ended March 31,
1998.

Gains and losses from  investments are allocated to partners'  capital  accounts
when realized, in accordance with the Partnership Agreement (see Note 3 of Notes
to Financial  Statements).  However,  for purposes of calculating  the net asset
value per unit of limited partnership interest,  net unrealized  appreciation of
investments  has been included as if such net unrealized  appreciation  had been
realized  and  allocated  to  the  limited   partners  in  accordance  with  the
Partnership  Agreement.  Pursuant to such  calculation,  the net asset value per
$1,000  Unit as of March  31,  1999 and  December  31,  1998 was $108 and  $117,
respectively.

Year 2000 Issue - The Year 2000 ("Y2K")  concern  arose  because  many  existing
computer  programs  use only the last two digits to refer to a year.  Therefore,
these computer  programs do not properly  recognize a year that begins with "20"
instead of "19".  If not  corrected,  many computer  applications  could fail or
create  erroneous  results.  The impact of the Y2K concern on the  Partnership's
operations is currently being assessed.

The Management Company is responsible to provide or arrange for the provision of
administrative services necessary to support the Partnership's  operations.  The
Management  Company has  arranged  for Palmeri Fund  Administrators,  Inc.  (the
"Administrator")  to provide certain  administrative and accounting services for
the  Partnership,  including  maintenance  of  the  books  and  records  of  the
Partnership,  maintenance of the limited partner database, issuance of financial
reports and tax  information  to limited  partners and  processing  distribution
payments  to  limited  partners.  Fees  charged  by the  Administrator  are paid
directly by the Management Company.

The  Administrator  has  assessed its  computer  hardware and software  systems,
specifically  as they relate to the  operations of the  Partnership.  As part of
this investigation of potential Y2K concerns, the Administrator  contracted with
an outside  computer  service  provider  to examine  all of the  Administrator's
computer hardware and software applications. This review and evaluation has been
completed.  The  Administrator  currently  is  in  the  process  of  purchasing,
installing, and testing the necessary software patches and new computer hardware
required to ensure that all of its  computer  systems  are Y2K  compliant.  This
correction phase is expected to be completed by September 1999.

Additionally, the Administrator has contacted the outside service providers used
to assist the Administrator or the Management Company with the administration of
the Partnership's  operations to ascertain whether these entities are addressing
the Y2K issue within  their own  operation.  There can be no guarantee  that the
Administrator's systems or that systems of other companies providing services to
the Partnership will be corrected in a timely manner.

Since the Partnership  does not own any equipment and all of its  administrative
needs  are  provided  by the  Management  Company,  any  costs  relating  to the
investigation   and   correction  of  potential   Y2K  concerns   affecting  the
Partnership's  operations will be incurred by the Administrator,  the Management
Company or the outside service providers.  Therefore, the Management Company and
the Managing  General  Partner do not expect the  Partnership to incur any costs
relating to the investigation or correction of Y2K concerns.

Finally the Y2K issue is a global concern that my affect all business  entities,
including  the  Partnership's  portfolio  companies.   The  General  Partner  is
continuing  to  assess  the  impact  of Y2K  concerns  affecting  its  portfolio
companies.  However, the extent to which any potential Y2K problems could affect
the  valuations  of these  companies  is  presently  unknown.  At the time  that
specific Y2K problems are identified,  if any, the Managing General Partner will
take  such  issues  into  consideration  in  adjusting  the  fair  value  of the
Partnership's portfolio investments.




Item 3.  Quantitative and Qualitative Disclosures about Market Risk

The  Partnership  is subject to market risk arising from changes in the value of
its portfolio  investments,  short-term  investments and  interest-bearing  cash
equivalents,  which may result from  fluctuations  in interest  rates and equity
prices.  The  Partnership has calculated its market risk related to its holdings
of these  investments  based on changes  in  interest  rates and  equity  prices
utilizing  a  sensitivity  analysis.  The  sensitivity  analysis  estimates  the
hypothetical  change in fair values, cash flows and earnings based on an assumed
10% change  (increase  or  decrease)  in interest  rates and equity  prices.  To
perform the  sensitivity  analysis,  the assumed 10% change is applied to market
rates  and  prices  on  investments  held by the  Partnership  at the end of the
accounting period.

The  Partnership's   portfolio  investments  had  an  aggregate  fair  value  of
$13,814,513  as of March 31, 1999.  An assumed 10% decline from this fair value,
including  an  assumed  10%  decline  of the  per  share  market  prices  of the
Partnership's  publicly-traded  securities,  would  result in a reduction to the
fair value of such investments and an unrealized loss of $1,381,451.

As of March 31, 1999, the Partnership  held discounted  commercial  paper with a
remaining  maturity of 55 days.  This  short-term  investment  was carried at an
aggregate  amortized  cost of  $496,249  as of March 31,  1999.  An assumed  10%
increase in the market interest rates of such short-term investments held by the
Partnership as of March 31, 1999,  would result in a reduction to the fair value
of such  investments  and an  unrealized  loss  which is also  considered  to be
immaterial.

Market risk  relating to the  Partnership's  interest-bearing  cash  equivalents
held as of March 31,  1999 is also  considered  to be immaterial.


<PAGE>

                           PART II - OTHER INFORMATION

Item 1.       Legal Proceedings.

Not applicable.

Item 2.       Changes in Securities.

Not applicable.

Item 3.       Defaults Upon Senior Securities.

Not applicable.

Item 4.       Submission of Matters to a Vote of Security Holders.

No matter was submitted to a vote of security  holders during the period covered
by this report.

Item 5.       Other Information.

Not applicable.


<PAGE>


Item 6.       Exhibits and Reports on Form 8-K.

              (a)   Exhibits

                    (3)   (a)  Amended and Restated  Certificate  of Limited  
                               Partnership of the  Partnership,  dated as of 
                               January 12,1987. (1)

                    (3)   (b)  Amended and Restated Certificate of Limited 
                               Partnership of the Partnership, dated July 27,
                               1990. (2)

                    (3)   (c)  Amended and Restated Certificate of Limited 
                               Partnership of the Partnership, dated March 25, 
                               1991. (3)

                    (3)   (d)  Amended and Restated Agreement of Limited
                               Partnership of the Partnership, dated as of
                               May 4, 1987. (4)

                    (3)   (e)  Amendment No. 1 dated February 14, 1989 to 
                               Amended and Restated Agreement of Limited  
                               Partnership of the Partnership. (5)

                    (3)   (f)  Amendment  No. 2 dated July 27, 1990 to Amended
                               and  Restated  Agreement of Limited  Partnership
                               of the Partnership. (2)

                    (3)   (g)  Amendment  No. 3 dated March 25, 1991 to Amended 
                               and Restated  Agreement of Limited  Partnership 
                               of the Partnership. (3)

                    (3)   (h)  Amendment  No. 4 dated May 23, 1991 to Amended 
                               and  Restated  Agreement  of Limited  Partnership
                               of the Partnership. (6)

                    (10)  (a)  Management  Agreement  dated as of May 23,  1991
                               among the Partnership, Management Company and the
                               Managing General Partner. (6)

                    (10)       (b) Sub-Management  Agreement dated as of May 23,
                               1991 among the Partnership,  Management  Company,
                               the Managing General Partner and the Sub-Manager.
                               (8)

                    (27)       Financial Data Schedule.

                    (28)       Prospectus of the Partnership  dated February 10,
                               1987  filed  with  the  Securities  and  Exchange
                               Commission  pursuant  to Rule  424(b)  under  the
                               Securities  Act of  1933,  as  supplemented  by a
                               supplement  thereto  dated  April 21,  1987 filed
                               pursuant to Rule 424(c) under the  Securities Act
                               of 1933. (7)

              (b)              No reports on Form 8-K have been filed during the
                               quarter for which this report is filed.


<PAGE>




 (1)     Incorporated by reference to the Partnership's  Annual Report on Form 
         10-K for the year ended December 31, 1988 filed with the
         Securities and Exchange Commission on March 27, 1989.

(2)      Incorporated by reference to the  Partnership's  Quarterly  Report on
         Form 10-Q for the quarter ended September 30, 1990 filed
         with the Securities and Exchange Commission on November 14, 1990.

(3)      Incorporated by reference to the Partnership's  Annual Report on Form 
         10-K for the year ended December 31, 1990 filed with the
         Securities and Exchange Commission on March 28, 1991.

(4)      Incorporated by reference to the  Partnership's  Quarterly  Report on 
         Form 10-Q for the quarter ended June 30, 1987 filed with
         the Securities and Exchange Commission on August 14, 1987.

(5)      Incorporated by reference to the  Partnership's  Quarterly Report on 
         Form 10-Q for the quarter ended March 31, 1989 filed with
         the Securities and Exchange Commission on May 15, 1989.

(6)      Incorporated by reference to the  Partnership's  Quarterly  Report on 
         Form 10-Q for the quarter ended June 30, 1991 filed with
         the Securities and Exchange Commission on August 14, 1991.

(7)      Incorporated by reference to the  Partnership's  Quarterly Report on 
         Form 10-Q for the quarter ended March 31, 1987 filed with
         the Securities and Exchange Commission on May 15, 1987.

(8)      Incorporated by reference to the Partnership's  Annual Report on Form 
         10-K for the year ended December 31, 1992 filed with the
         Securities and Exchange Commission on March 26, 1993.



<PAGE>


                                                              SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



              ML VENTURE PARTNERS II, L.P.


By:           MLVPII Co., L.P.,
              its Managing General Partner

By:           Merrill Lynch Venture Capital Inc.,
              its General Partner


By:           /s/     Kevin K. Albert                         
              Kevin K. Albert
              President
              (Principal Executive Officer)


By:           /s/      David G. Cohen                     
              David G. Cohen
              Vice President


By:           /s/     Diane T. Herte                          
              Diane T. Herte
              Vice President and Treasurer
              (Principal Financial and Accounting Officer)



Date:         May 14, 1999


<TABLE> <S> <C>


<ARTICLE>                                                                      6
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM ML VENTURE
PARTNERS II, L.P.'S QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED MARCH 31,
1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                                                                          <C>
<PERIOD-TYPE>                                                              3-MOS
<FISCAL-YEAR-END>                                                    DEC-31-1999
<PERIOD-START>                                                        JAN-1-1999
<PERIOD-END>                                                         MAR-31-1999
<INVESTMENTS-AT-COST>                                                  9,834,307
<INVESTMENTS-AT-VALUE>                                                13,814,513
<RECEIVABLES>                                                                  0
<ASSETS-OTHER>                                                                 0
<OTHER-ITEMS-ASSETS>                                                     753,684
<TOTAL-ASSETS>                                                        14,568,197
<PAYABLE-FOR-SECURITIES>                                                       0
<SENIOR-LONG-TERM-DEBT>                                                        0
<OTHER-ITEMS-LIABILITIES>                                                189,545
<TOTAL-LIABILITIES>                                                      189,545
<SENIOR-EQUITY>                                                                0
<PAID-IN-CAPITAL-COMMON>                                                       0
<SHARES-COMMON-STOCK>                                                    120,000
<SHARES-COMMON-PRIOR>                                                    120,000
<ACCUMULATED-NII-CURRENT>                                                      0
<OVERDISTRIBUTION-NII>                                                         0
<ACCUMULATED-NET-GAINS>                                                        0
<OVERDISTRIBUTION-GAINS>                                                       0
<ACCUM-APPREC-OR-DEPREC>                                               3,980,206
<NET-ASSETS>                                                          14,378,652
<DIVIDEND-INCOME>                                                              0
<INTEREST-INCOME>                                                         23,502
<OTHER-INCOME>                                                                 0
<EXPENSES-NET>                                                           127,292
<NET-INVESTMENT-INCOME>                                                (103,790)
<REALIZED-GAINS-CURRENT>                                                       0
<APPREC-INCREASE-CURRENT>                                              (792,382)
<NET-CHANGE-FROM-OPS>                                                (1,259,550)
<EQUALIZATION>                                                                 0
<DISTRIBUTIONS-OF-INCOME>                                                      0
<DISTRIBUTIONS-OF-GAINS>                                                       0
<DISTRIBUTIONS-OTHER>                                                          0
<NUMBER-OF-SHARES-SOLD>                                                        0
<NUMBER-OF-SHARES-REDEEMED>                                                    0
<SHARES-REINVESTED>                                                            0
<NET-CHANGE-IN-ASSETS>                                               (1,259,550)
<ACCUMULATED-NII-PRIOR>                                                        0
<ACCUMULATED-GAINS-PRIOR>                                                      0
<OVERDISTRIB-NII-PRIOR>                                                        0
<OVERDIST-NET-GAINS-PRIOR>                                                     0
<GROSS-ADVISORY-FEES>                                                          0
<INTEREST-EXPENSE>                                                             0
<GROSS-EXPENSE>                                                                0
<AVERAGE-NET-ASSETS>                                                  15,008,427
<PER-SHARE-NAV-BEGIN>                                                        117
<PER-SHARE-NII>                                                              (1)
<PER-SHARE-GAIN-APPREC>                                                      (8)
<PER-SHARE-DIVIDEND>                                                           0
<PER-SHARE-DISTRIBUTIONS>                                                      0
<RETURNS-OF-CAPITAL>                                                           0
<PER-SHARE-NAV-END>                                                          108
<EXPENSE-RATIO>                                                                0
<AVG-DEBT-OUTSTANDING>                                                         0
<AVG-DEBT-PER-SHARE>                                                           0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission